Related Experiment Video

Updated: Apr 28, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.5K

Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for

Xiao-Dong Liang1, Yue-Chu Dai2, Zhao-Yun Li2

  • 1Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, First People's Hospital, Hangzhou, China.

Plos One
|June 7, 2014
PubMed

Insights

Mitotic spindle checkpoint genes are crucial for hepatocellular carcinoma (HCC) proliferation. TTK, a key gene, is overexpressed in HCC and linked to sorafenib resistance, making it a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mitotic spindle checkpoint (SAC) genes are potential anticancer targets.
  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Identifying novel therapeutic targets for HCC is critical.

Purpose of the Study:

  • To identify key mitotic spindle checkpoint (SAC) genes for hepatocellular carcinoma (HCC) therapy.
  • To investigate the role of SAC genes in HCC proliferation and sorafenib resistance.

Main Methods:

  • Expression profile analysis of 137 SAC genes in HCC vs. normal tissues.
  • Small interfering RNA (siRNA) knockdown to assess gene function in HCC cells.
  • Establishment of sorafenib-resistant HCC cell lines for further analysis.
  • In vitro and in vivo functional assays to evaluate TTK's role.

Main Results:

  • 13 SAC genes were significantly upregulated in HCC tissues.
  • Several SAC genes were essential for HCC cell proliferation.
  • Increased TTK expression correlated with sorafenib resistance in HCC cells.
  • TTK overexpression promoted HCC proliferation and sorafenib resistance; TTK knockdown inhibited these processes.

Conclusions:

  • TTK plays a critical role in HCC cell proliferation and sorafenib resistance.
  • TTK is a promising therapeutic target for human hepatocellular carcinoma.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

7.7K
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K